Hulusi Behçet

Specializzazione: Rheumatologist
Studio medico: Turchia, Istanbul, Prof. Dr. Şule Güngör
- Specialist at the clinic: Prof. Dr. Hulusi Behçet’s name is linked to Behçet’s Disease, which the clinic profile notes was first described in 1937.
- At the clinic, Behçet’s Disease is treated as a chronic, systemic vasculitis affecting vessels of different sizes throughout the body.
- Diagnostic work-up at the clinic includes the Pathergy test, which evaluates an exaggerated skin inflammatory response to minor trauma.
- Clinical monitoring is described as multidisciplinary, involving rheumatology, dermatology, and ophthalmology for symptoms such as oral sores, genital ulcers, skin lesions, joint pain, and eye involvement.
Prof. Dr. Hulusi Behçet is presented by the clinic as the physician who first described Behçet’s Disease in 1937. As a specialist at the clinic, the focus is on Behçet’s Disease as a chronic, systemic vasculitis, with diagnosis supported by clinical findings and a Pathergy test. The clinic describes coordinated follow-up with rheumatology, dermatology, and ophthalmology to manage oral sores, genital ulcers, skin lesions, joint pain, and eye involvement.

Servizi medici

Test cutaneo con puntura

Com'è andata la tua esperienza?

1 di 3

Le informazioni su questo medico sono complete e chiare

Totalmente in disaccordo

Totalmente d'accordo

Formazione accademica

Behçet’s Disease is described at the clinic as a chronic, systemic vasculitis—an inflammatory process driven by an abnormal immune response that targets blood vessels. The clinic materials note that the condition was first described in 1937 by Prof. Dr. Hulusi Behçet and introduced into medical literature. As a specialist at the clinic, the approach emphasizes that symptoms can occur in multiple organs, not just one site. Clinically, the clinic highlights a classic pattern that includes recurrent oral sores (aphthae), genital ulcers, and skin lesions, with a course that alternates between attacks and recovery periods. It also explains that oral aphthae are often extremely painful, may recur frequently, and can significantly impair quality of life. For diagnosis, the clinic states that there is no single laboratory blood test that definitively confirms Behçet’s Disease; instead, physicians rely on clinical findings and physician observation, using internationally accepted diagnostic criteria. A key diagnostic tool described is the Pathergy test, which measures hypersensitivity of the skin to trauma. The test involves making small punctures on the inner forearm with a sterile needle tip, without injecting medication or substances, to observe whether an exaggerated inflammatory response develops. The clinic also describes skin manifestations such as papulopustular lesions that can resemble acne-like bumps but are interpreted as vascular inflammation during active disease. For treatment planning and follow-up, the clinic describes a multidisciplinary process involving rheumatology, dermatology, and ophthalmology. It lists immunosuppressive drugs, colchicine, and corticosteroid treatments as part of evidence-based protocols used to control symptoms and prevent complications, including eye involvement and joint pain.

Education

No specific education details are provided in the clinic materials for this doctor.

Work experience

No specific work-history details are provided in the clinic materials for this doctor.

Clinical focus and techniques

At the clinic, Behçet’s Disease management centers on recognizing systemic vasculitis features and applying diagnostic criteria supported by targeted testing.

Behçet’s Disease treatment for chronic systemic vasculitis affecting vessels of different sizes.
Pathergy test as a skin hypersensitivity test to minor trauma.
Multidisciplinary follow-up described with rheumatology, dermatology, and ophthalmology.
Medication protocols described include immunosuppressive drugs, colchicine, and corticosteroids.

Professional societies and certifications

No specific society memberships or certifications are provided in the clinic materials for this doctor.

Academic output

No specific publications, h-index, or academic metrics are provided in the clinic materials for this doctor.

Courses and advanced training

No specific courses or advanced training details are provided in the clinic materials for this doctor.

Awards and recognition

1937 — Behçet’s Disease first described by Prof. Dr. Hulusi Behçet (as stated in the clinic materials).

Practice is presented through the clinic’s Istanbul dermatology context, with coordination across specialties when Behçet’s Disease affects the eyes, joints, skin, or mucosa. For patients traveling internationally, the clinic’s focus on structured diagnostic criteria and multidisciplinary monitoring is designed to support consistent follow-up during active and remission phases.